GSK lab fined over vaccine tests that killed 14 babies

GlaxoSmithKline Argentina Laboratories company was fined 400,000 pesos (92,721.37 U$D) by Judge Marcelo Aguinsky following a report issued by the National Administration of Medicine, Food and Technology (ANMAT in Spanish) for the killing of 14 babies during illegal lab vaccine trials conducted between 2007 and 2008.

Likewise, two doctors -Héctor Abate, and Miguel Tregnaghi- were fined with 300,000 pesos (69,541.03 U$D) each, for irregularities during the studies.

The charges included experimenting with human beings, falsifying parental authorizations so babies could participate in vaccine-trials conducted by the laboratory from 2007 to 2008.
Read more: www.buenosairesherald.com/article/88922/gsk-lab-fined-$1m-over-tests-that-killed-14--babies

Glaxo Settles Cases With U.S. for $3 Billion

The cases against GlaxoSmithKline include illegal marketing of Avandia, a diabetes drug that was severely restricted last year after it was linked to heart risks. Federal prosecutors said the company had paid doctors and manipulated medical research to promote the drug.

GlaxoSmithKline, with a market value of more than $110 billion, had net profit of about $5 billion on sales of $43 billion in the year ending Sept. 30.

Critics of the settlements made with drug companies argued for stiffer penalties, including prison sentences for corporate officials.
Read more: www.nytimes.com/2011/11/04/business/glax...settlement.html?_r=1

Excess in the pharmaceutical industry

The medical profession has largely abdicated its responsibility to educate medical students and doctors in the use of prescription drugs. Drug companies now support most continuing medical education, medical conferences and meetings of professional associations - The industry also provides students, house officers and physicians in practice with meals, trips to exotic locations and many other blandishments - And so why does the profession pretend to believe that drug companies, in contrast with all other businesses, can provide objective information about their own products?
Read more: canadianmedicaljournal.ca/content/171/12/1451.full

Glaxo to Pay $750 Million for Sale of Bad Products

GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant — the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines.

Altogether, GlaxoSmithKline sold 20 drugs with questionable safety that were made at a huge plant in Puerto Rico that for years was rife with contamination - Among the drugs affected were Paxil, an antidepressant; Bactroban, an ointment; Avandia, a troubled diabetes drug; Coreg, a heart drug; and Tagamet, an acid reflux drug. No patients were known to have been sickened, although such cases would be difficult to trace.
Read more: www.nytimes.com/2010/10/27/business/27drug.html?pagewanted=all

HEALTH CANADA; also traded as: THE GOVERNMENT OF CANADA, contracted with this same, pharmaceutical [DRUG] giant, to manufacture for them, 'their' 2009 H1N1 Pandemic Swine Flu Vaccine, with "AS03-Adjuvant" (a very controversial chemical cocktail) - Arepanrix™ H1N1

HEALTH CANADA has authorized the sale of Arepanrix™ H1N1 based on limited clinical testing in humans under the provision of an Interim Order (IO) issued on October 13, 2009
Read more: www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/...dinfo-vaccin-eng.pdf